September 08, 2023—Social and technological changes have elevated the amount of potential harm a rogue employee can do. Here’s what the general counsel should know.
September 08, 2023—In-house counsel should coordinate inside leaders and outside advisors to respond to a crisis. But they also have a role in longer-term response.Preparing for the Inevitable Black Swan
September 07, 2023—A black swan event is rare, catastrophic and defies prediction. But there are ways to mitigate, and even minimize, the resulting crisis.Missteps the GC Should Avoid in the First 48 Hours of a Crisis
September 05, 2023—The urge to spring into action when crisis strikes is instinctive. Strategic tactics can scale back pressure on the GC to launch an effective response.The GC and ESG: From Great Risk Comes Great Opportunity
August 28, 2023—General counsels increasingly lead the charge for meeting company ESG standards. Here’s how they can identify opportunities for creating shareholder value.Can I Speed Up the Pathway to FDA Approval of My New Drug?
August 16, 2023—As pharma and biotech firms face ever-increasing pressure to bring their products to market, many are asking how to expedite going from bench to bedside.The SEC’s Revised Cybersecurity Rules Have Global Reach
August 01, 2023—If your company is publicly traded in the U.S. — whether headquartered in the U.S. or abroad — new cybersecurity and disclosure rules apply.The Four Risks of the EU’s Artificial Intelligence Act: Is Your Company Ready?
July 25, 2023—The Act divides AI systems into four risk categories that range from minimal to unacceptable. Knowing the differences is critical for compliance.